SUPERNUS PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 41.13 million shares for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2014-05-13
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2014-03-31 was 41.13M shares, a 33.21% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2013-12-31 was 34.68M shares, a 29.91% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2013-09-30 was 30.94M shares, a 26.48% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2013-06-30 was 30.90M shares, a 83.72% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 31.85M shares, a 82.61% increase from fiscal 2012.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2012 was 17.44M shares, a 986.44% increase from fiscal 2011.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2011 was 1.61M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2014-03-31 | 41.13M shares 10-Q · filed 2014-05-13 | 37.90M shares derived: average of 2 quarters · filed 2014-05-13 | 35.58M shares derived: average of 3 quarters · filed 2014-05-13 | 34.41M shares derived: average of 4 quarters · filed 2014-05-13 |
| 2013-12-31 | 34.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | 32.81M shares derived: average of 2 quarters · filed 2014-03-21 | 32.17M shares derived: average of 3 quarters · filed 2014-03-21 | 31.85M shares 10-K · filed 2014-03-21 |
| 2013-09-30 | 30.94M shares 10-Q · filed 2013-11-13 | 30.92M shares derived: average of 2 quarters · filed 2013-11-13 | 30.90M shares 10-Q · filed 2013-11-13 | 29.85M shares derived: average of 4 quarters · filed 2014-05-13 |
| 2013-06-30 | 30.90M shares 10-Q · filed 2013-08-14 | 30.89M shares 10-Q · filed 2013-08-14 | 29.49M shares derived: average of 3 quarters · filed 2014-05-13 | 28.23M shares derived: average of 4 quarters · filed 2014-05-13 |
| 2013-03-31 | 30.88M shares 10-Q · filed 2014-05-13 | 28.78M shares derived: average of 2 quarters · filed 2014-05-13 | 27.34M shares derived: average of 3 quarters · filed 2014-05-13 | 24.71M shares derived: average of 4 quarters · filed 2014-05-13 |
| 2012-12-31 | 26.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | 25.58M shares derived: average of 2 quarters · filed 2014-03-21 | 22.66M shares derived: average of 3 quarters · filed 2014-03-21 | 17.44M shares 10-K · filed 2014-03-21 |
| 2012-09-30 | 24.46M shares 10-Q · filed 2013-11-13 | 20.64M shares derived: average of 2 quarters · filed 2013-11-13 | 14.36M shares 10-Q · filed 2013-11-13 | 11.15M shares derived: average of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | 16.82M shares 10-Q · filed 2013-08-14 | 9.25M shares 10-Q · filed 2013-08-14 | 6.71M shares derived: average of 3 quarters · filed 2014-03-21 | 5.43M shares derived: average of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | 1.68M shares 10-Q · filed 2013-05-15 | 1.66M shares derived: average of 2 quarters · filed 2014-03-21 | 1.64M shares derived: average of 3 quarters · filed 2014-03-21 | |
| 2011-12-31 | 1.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | 1.62M shares derived: average of 2 quarters · filed 2014-03-21 | 1.61M shares 10-K · filed 2014-03-21 | |
| 2011-09-30 | 1.60M shares 10-Q · filed 2012-11-02 | 1.59M shares 10-Q · filed 2012-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |